Keyphrases
Non-alcoholic Fatty Liver Disease (NAFLD)
100%
Anti-inflammatory Potential
100%
ATTICA Study
100%
Anti-inflammation
33%
Inflammation Index
33%
Anti-inflammatory Diet
26%
Hepatic Steatosis Index
20%
Triglyceride-glucose Index
20%
Fatty Liver Index
20%
Confidence Interval
13%
Odds Ratio
13%
Subclinical Cardiovascular Disease
13%
Epidemiological Data
6%
Sociodemographic Characteristics
6%
Dietary Habits
6%
Disease Prevention
6%
Clinical Characteristics
6%
Cardiovascular Disease
6%
Fatty Liver
6%
Prospective Cohort Study
6%
Assessment Index
6%
Metabolic Syndrome
6%
Characteristic Markers
6%
Inverse Association
6%
Lifestyle Characteristics
6%
Inflammatory Potential
6%
Disease-free
6%
Low-grade Inflammation
6%
Greek Population
6%
Hepatic Markers
6%
Disease Assessment
6%
White People
6%
Alcohol Drinkers
6%
Medicine and Dentistry
Nonalcoholic Fatty Liver
100%
Anti-Inflammatory Drug
100%
Fatty Liver
46%
Cardiovascular Disease
20%
Triacylglycerol
13%
Odds Ratio
13%
Metabolic Syndrome
6%
Dietary Habit
6%
White Population
6%
Disease Assessment
6%
Nutrition
6%
Triglyceride-Glucose Index
6%
Pharmacology, Toxicology and Pharmaceutical Science
Anti-Inflammatory Drug
100%
Nonalcoholic Fatty Liver
100%
Fatty Liver
46%
Anti-Inflammation
33%
Triacylglycerol
20%
Cardiovascular Disease
20%
Metabolic Syndrome X
6%
Inflammation
6%